Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

3 Cheap Manufacturing Stocks Pushing Past New Highs: https://www.marketbeat.com/logos/articles/med_20230809093235_3-cheap-manufacturing-stocks-pushing-past-new-high.jpg
3 Cheap Manufacturing Stocks Pushing Past New Highs

As the United States economy begins to face its next central inflection point or, put, a potential pivot into a lower gear, some industries begin to receive differentiated treatment from the

3 Cheap Manufacturing Stocks Pushing Past New Highs: https://www.marketbeat.com/logos/articles/med_20230809093235_3-cheap-manufacturing-stocks-pushing-past-new-high.jpg
3 Cheap Manufacturing Stocks Pushing Past New Highs

As the United States economy begins to face its next central inflection point or, put, a potential pivot into a lower gear, some industries begin to receive differentiated treatment from the

3 Stocks to Buy After Heavy Insider Buying: https://www.marketbeat.com/logos/articles/med_20230809073136_3-stocks-to-buy-after-heavy-insider-buying.jpg
3 Stocks to Buy After Heavy Insider Buying

Many investors are motivated to sell a stock when they notice that company insiders are dumping their shares. However, company insiders can sell a stock for many reasons, and many of those have

Novo Nordisk Soars To New High On Weight-Loss  Drug Trial Results: https://www.marketbeat.com/logos/articles/med_20230809072355_novo-nordisk-soars-to-new-high-on-weight-loss-drug.jpg
Novo Nordisk Soars To New High On Weight-Loss Drug Trial Results

Weight-loss drugs are the pharmaceutical industry’s equivalent of AI, in the sense of being a product with the capability to send shares soaring. Novo Nordisk A/S (NYSE: NVO), maker of Wegovy, saw

Eilt: 20 Mrd. $ Übernahme - Börsenstar startet jetzt diese Aktie. Massives Kaufsignal. Neuer 481% Security SoftwareAktientip nach 788% mit den Security Software-Aktien von Crowdstrike Holdings ($CRWD), 1.229% mit Okta Corp ($OKTA), 1.855% mit Palo Al: https://www.irw-press.at/prcom/images/messages/2023/71591/AC_VSBLTY_090823.002.jpeg
Eilt: 20 Mrd. $ Übernahme - Börsenstar startet jetzt diese Aktie. Massives Kaufsignal. Neuer 481% Security SoftwareAktientip nach 788% mit den Security Software-Aktien von Crowdstrike Holdings ($CRWD), 1.229% mit Okta Corp ($OKTA), 1.855% mit Palo Al

Sensationelle 20 Mrd. $ Übernahme - Börsenstar startet jetzt diese Aktie. 268% Security Software Aktientip nach 6.765%

 

09.08.23 08:17

AC Research

 

Vancouver (www.aktiencheck.de, Anzeige)

 

Eilt: 20 Mrd. $ Übernahme - Börsenstar startet jetzt diese Aktie. Massives Kaufsignal. Neuer 481% Security SoftwareAktientip nach 788% mit den Security Software-Aktien von Crowdstrike Holdings ($CRWD), 1.229% mit Okta Corp ($OKTA), 1.855% mit Palo Al: https://www.irw-press.at/prcom/images/messages/2023/71591/AC_VSBLTY_090823.002.jpeg
Eilt: 20 Mrd. $ Übernahme - Börsenstar startet jetzt diese Aktie. Massives Kaufsignal. Neuer 481% Security SoftwareAktientip nach 788% mit den Security Software-Aktien von Crowdstrike Holdings ($CRWD), 1.229% mit Okta Corp ($OKTA), 1.855% mit Palo Al

Sensationelle 20 Mrd. $ Übernahme - Börsenstar startet jetzt diese Aktie. 268% Security Software Aktientip nach 6.765%

 

09.08.23 08:17

AC Research

 

Vancouver (www.aktiencheck.de, Anzeige)

 

Eilt: 20 Mrd. $ Übernahme - Börsenstar startet jetzt diese Aktie. Massives Kaufsignal. Neuer 481% Security SoftwareAktientip nach 788% mit den Security Software-Aktien von Crowdstrike Holdings ($CRWD), 1.229% mit Okta Corp ($OKTA), 1.855% mit Palo Al: https://www.irw-press.at/prcom/images/messages/2023/71591/AC_VSBLTY_090823.002.jpeg
Eilt: 20 Mrd. $ Übernahme - Börsenstar startet jetzt diese Aktie. Massives Kaufsignal. Neuer 481% Security SoftwareAktientip nach 788% mit den Security Software-Aktien von Crowdstrike Holdings ($CRWD), 1.229% mit Okta Corp ($OKTA), 1.855% mit Palo Al

Sensationelle 20 Mrd. $ Übernahme - Börsenstar startet jetzt diese Aktie. 268% Security Software Aktientip nach 6.765%

 

09.08.23 08:17

AC Research

 

Vancouver (www.aktiencheck.de, Anzeige)

 

Eilt: 20 Mrd. $ Übernahme - Börsenstar startet jetzt diese Aktie. Massives Kaufsignal. Neuer 481% Security SoftwareAktientip nach 788% mit den Security Software-Aktien von Crowdstrike Holdings ($CRWD), 1.229% mit Okta Corp ($OKTA), 1.855% mit Palo Al: https://www.irw-press.at/prcom/images/messages/2023/71591/AC_VSBLTY_090823.002.jpeg
Eilt: 20 Mrd. $ Übernahme - Börsenstar startet jetzt diese Aktie. Massives Kaufsignal. Neuer 481% Security SoftwareAktientip nach 788% mit den Security Software-Aktien von Crowdstrike Holdings ($CRWD), 1.229% mit Okta Corp ($OKTA), 1.855% mit Palo Al

Sensationelle 20 Mrd. $ Übernahme - Börsenstar startet jetzt diese Aktie. 268% Security Software Aktientip nach 6.765%

 

09.08.23 08:17

AC Research

 

Vancouver (www.aktiencheck.de, Anzeige)

 

Sensation: Hautkrebs vollständig geheilt durch diesen Biotech Aktientip - Massives Kaufsignal. Neuer 207% Biotech Aktientip  nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2023/71589/AC_Vidac_090823.001.png
Sensation: Hautkrebs vollständig geheilt durch diesen Biotech Aktientip - Massives Kaufsignal. Neuer 207% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Sensation: Hautkrebs vollständig geheilt durch diesen Biotech Aktientip. 207% Biotech Hot Stock nach 134.452% mit Biogen

 

09.08.23 08:02

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

Sensation: Hautkrebs vollständig geheilt durch diesen Biotech Aktientip - Massives Kaufsignal. Neuer 207% Biotech Aktientip  nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2023/71589/AC_Vidac_090823.001.png
Sensation: Hautkrebs vollständig geheilt durch diesen Biotech Aktientip - Massives Kaufsignal. Neuer 207% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Sensation: Hautkrebs vollständig geheilt durch diesen Biotech Aktientip. 207% Biotech Hot Stock nach 134.452% mit Biogen

 

09.08.23 08:02

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

Sensation: Hautkrebs vollständig geheilt durch diesen Biotech Aktientip - Massives Kaufsignal. Neuer 207% Biotech Aktientip  nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2023/71589/AC_Vidac_090823.001.png
Sensation: Hautkrebs vollständig geheilt durch diesen Biotech Aktientip - Massives Kaufsignal. Neuer 207% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Sensation: Hautkrebs vollständig geheilt durch diesen Biotech Aktientip. 207% Biotech Hot Stock nach 134.452% mit Biogen

 

09.08.23 08:02

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

MAG Silver meldet Finanzergebnisse für das zweite Quartal: https://www.irw-press.at/prcom/images/messages/2023/71583/08-08-23MAGNR23-15FinancialFINAL_DE.001.png
MAG Silver meldet Finanzergebnisse für das zweite Quartal

 

Vancouver, British Columbia. MAG Silver Corp. (TSX / NYSE American: MAG) („MAG“, „MAG Silver“ oder das „Unternehmen“ - https://www.commodity-tv.com/ondemand/companies/profil/mag-silver-corp

MAG Silver Reports Second Quarter Financial Results: https://www.irw-press.at/prcom/images/messages/2023/71583/08-08-23NR23-MAGFinancialFINAL_EN.001.png
MAG Silver Reports Second Quarter Financial Results

 

Vancouver, B.C. MAG Silver Corp. (TSX / NYSE American: MAG) (“MAG”, or the “Company” - https://www.commodity-tv.com/ondemand/companies/profil/mag-silver-corp/) announces the Company’s

UPS Slipping To More Attractive Levels On Weak Outlook: https://www.marketbeat.com/logos/articles/med_20230808084145_chart-ups-882023.png
UPS Slipping To More Attractive Levels On Weak Outlook

The United Parcel Service, Inc (NYSE: UPS) story is unchanged; internal improvements are offset by economic headwinds and canceling each other. The takeaway is that range-bound UPS is still

More Good News Coming? GoodRx Spikes Ahead of Q2 Earnings: https://www.marketbeat.com/logos/articles/med_20230808084028_more-good-news-coming-goodrx-spikes-ahead-of-q2-ea.jpg
More Good News Coming? GoodRx Spikes Ahead of Q2 Earnings

When GoodRx Holdings, Inc. (NASDAQ:GDRX) burst onto the scene in the middle of the pandemic, it brought promises of saving Americans money on their drug prescriptions. While consumers have indeed

More Good News Coming? GoodRx Spikes Ahead of Q2 Earnings: https://www.marketbeat.com/logos/articles/med_20230808084028_more-good-news-coming-goodrx-spikes-ahead-of-q2-ea.jpg
More Good News Coming? GoodRx Spikes Ahead of Q2 Earnings

When GoodRx Holdings, Inc. (NASDAQ:GDRX) burst onto the scene in the middle of the pandemic, it brought promises of saving Americans money on their drug prescriptions. While consumers have indeed

‘Dogs of the Dow’ Decade Edition...More Pains or Gains Ahead?: https://www.marketbeat.com/logos/articles/med_20230808083355_dogs-of-the-dow-decade-edition.jpg
‘Dogs of the Dow’ Decade Edition...More Pains or Gains Ahead?

The ‘Dogs of the Dow’ investment strategy became popular in the early 1990’s when author Michael O’Higgins wrote a book titled “Beating the Dow - A High Return, Low-Risk Method for Investing in

‘Dogs of the Dow’ Decade Edition...More Pains or Gains Ahead?: https://www.marketbeat.com/logos/articles/med_20230808083355_dogs-of-the-dow-decade-edition.jpg
‘Dogs of the Dow’ Decade Edition...More Pains or Gains Ahead?

The ‘Dogs of the Dow’ investment strategy became popular in the early 1990’s when author Michael O’Higgins wrote a book titled “Beating the Dow - A High Return, Low-Risk Method for Investing in

Palantir Slips: An Entry Point Comes Into Focus: https://www.marketbeat.com/logos/articles/med_20230808074547_palantir-slips-an-entry-point-comes-into-focus.jpg
Palantir Slips: An Entry Point Comes Into Focus

Palantir (NASDAQ: PLTR) stock price hit a top before the Q2 earnings release and is pulling back now that the news is in. However, it is unlikely the post-release pullback will result in a

Palantir Slips: An Entry Point Comes Into Focus: https://www.marketbeat.com/logos/articles/med_20230808074547_palantir-slips-an-entry-point-comes-into-focus.jpg
Palantir Slips: An Entry Point Comes Into Focus

Palantir (NASDAQ: PLTR) stock price hit a top before the Q2 earnings release and is pulling back now that the news is in. However, it is unlikely the post-release pullback will result in a

Tyson Foods: Is There Any Meat On This Bone?: https://www.marketbeat.com/logos/articles/med_20230807121314_chart-tsn-872023.png
Tyson Foods: Is There Any Meat On This Bone?

Tyson Foods (NYSE: TSN) is trying hard to put in a bottom, and the bottom may be in. The Q3 results weren’t great and sparked a 7% decline in share prices that buyers met. This is not the first

Citigroup, Wells Fargo, PNC: Undervalued Dividend Growers: https://www.marketbeat.com/logos/articles/med_20230808072350_citigroup-wells-fargo-pnc-undervalued-dividend-gro.jpg
Citigroup, Wells Fargo, PNC: Undervalued Dividend Growers

If you’re exploring dividend stocks, you can adopt various strategies. You might seek out high-yield stocks, or those with consistent payouts and robust financial conditions, or companies with a

2 Stocks that Doubled Earnings Estimates and Sold Off: https://www.marketbeat.com/logos/articles/med_20230806161421_chart-lng.jpg
2 Stocks that Doubled Earnings Estimates and Sold Off

With the second-quarter 2023 earnings season underway, many earnings reaction trends are taking place. Companies that beat earnings estimates and raise guidance usually see their stocks gap and go

3 Hot Beverage Stocks Trading At Trigger Points: https://www.marketbeat.com/logos/articles/med_20230807104219_chart-sbux-872023.png
3 Hot Beverage Stocks Trading At Trigger Points

Beverage stocks have been hot this year, with gains ranging from the high-single-digits to roughly 50% for names like Starbucks. While the gains are not distributed evenly, the leaders are

3 Hot Beverage Stocks Trading At Trigger Points: https://www.marketbeat.com/logos/articles/med_20230807104219_chart-sbux-872023.png
3 Hot Beverage Stocks Trading At Trigger Points

Beverage stocks have been hot this year, with gains ranging from the high-single-digits to roughly 50% for names like Starbucks. While the gains are not distributed evenly, the leaders are